GT200600397A - Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales - Google Patents

Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales

Info

Publication number
GT200600397A
GT200600397A GT200600397A GT200600397A GT200600397A GT 200600397 A GT200600397 A GT 200600397A GT 200600397 A GT200600397 A GT 200600397A GT 200600397 A GT200600397 A GT 200600397A GT 200600397 A GT200600397 A GT 200600397A
Authority
GT
Guatemala
Prior art keywords
odv
venlafaxina
desmetil
topic
salts
Prior art date
Application number
GT200600397A
Other languages
English (en)
Inventor
Rao Tatapudy
Syed M Shah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37517243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600397A publication Critical patent/GT200600397A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

LA PRESENTE INVENCIÓN DA A CONOCER COMPOSICIONES TÓPICAS QUE COMPRENDEN O-DESMETILVENILAFAXINA (ODV), UN INHIBIDOR SELECTIVO DE LA SEROTONINA Y NOREPINEFRINA, O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DE LA MISMA. EN CIERTAS REALIZACIONES, LAS FORMULACIONES TÓPICAS DE LA PRESENTE INVENCIÓN CONTIENEN UNO O MÁS POTENCIADORES DE LA ABSORCIÓN PERCUTÁNEA/PERMUCOSAL. TAMBIÉN SE PRESENTAN MÉTODOS PARA LA PREPARACIÓN Y USO DE ESTAS COMPOSICIONES PARA EL TRATAMIENTO DE DIVERSAS ENFEREMDADES Y TRASTORNOS TALES COMO LOS SÍNTOMAS VASOMOTORES Y EL DOLOR. T2006
GT200600397A 2005-09-07 2006-08-31 Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales GT200600397A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71540005P 2005-09-07 2005-09-07

Publications (1)

Publication Number Publication Date
GT200600397A true GT200600397A (es) 2007-08-28

Family

ID=37517243

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600397A GT200600397A (es) 2005-09-07 2006-08-31 Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales

Country Status (18)

Country Link
US (1) US20070054964A1 (es)
EP (1) EP1924251A1 (es)
JP (1) JP2009507078A (es)
KR (1) KR20080041695A (es)
CN (1) CN101300002A (es)
AR (1) AR055629A1 (es)
AU (1) AU2006287580A1 (es)
BR (1) BRPI0615769A2 (es)
CA (1) CA2620164A1 (es)
CR (1) CR9751A (es)
EC (1) ECSP088251A (es)
GT (1) GT200600397A (es)
IL (1) IL189598A0 (es)
NO (1) NO20080950L (es)
PE (1) PE20070430A1 (es)
RU (1) RU2008106932A (es)
TW (1) TW200744566A (es)
WO (1) WO2007030537A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2010CN00695A (es) * 2007-07-12 2010-08-27 Reddys Lab Ltd Dr
CA2702664A1 (en) * 2007-10-16 2009-04-23 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
EP2212301B1 (en) * 2007-11-28 2012-02-29 Fresenius Kabi Oncology Limited An improved process for preparation of letrozole and its intermediates
EP2085377A1 (en) * 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
WO2009155488A2 (en) * 2008-06-19 2009-12-23 Segrub, Llc Novel oxalate salt and crystal of o-desmethylvenlafaxine
WO2010028130A2 (en) * 2008-09-03 2010-03-11 Concert Pharmaceuticals, Inc. Antidepressant compounds
KR101477155B1 (ko) * 2010-10-01 2014-12-29 산동 루예 파마슈티칼 컴파니 리미티드 4-[2-디메틸아미노-1-(1-하이드록시사이클로헥실)에틸]페닐 4-메틸벤조에이트 하이드로클로라이드의 다형체, 이의 제조 방법 및 이의 용도
WO2013063794A1 (en) * 2011-11-04 2013-05-10 Oil Crops Research Institute, Chinese Academy Of Agricultural Sciences A growth regulatory factor gene grf2 derived from brassica napus and the use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2000059851A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
US20020192302A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of antidepressant drugs using basic enhancers
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
MXPA03007043A (es) * 2001-02-12 2003-11-18 Wyeth Corp Nueva sal de succinato de o-desmetil-venlafaxina.
TW200407108A (en) * 2002-06-10 2004-05-16 Wyeth Corp Novel formate salt of O-desmethyl-venlafaxine
US7345096B2 (en) * 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
AU2004270113A1 (en) * 2003-08-26 2005-03-17 Becton, Dickinson And Company Methods for intradermal delivery of therapeutics agents
AU2004305563C1 (en) * 2003-12-11 2011-07-07 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein

Also Published As

Publication number Publication date
ECSP088251A (es) 2008-04-28
CN101300002A (zh) 2008-11-05
WO2007030537A1 (en) 2007-03-15
PE20070430A1 (es) 2007-05-18
JP2009507078A (ja) 2009-02-19
AR055629A1 (es) 2007-08-29
CR9751A (es) 2008-05-22
NO20080950L (no) 2008-05-26
AU2006287580A1 (en) 2007-03-15
TW200744566A (en) 2007-12-16
EP1924251A1 (en) 2008-05-28
KR20080041695A (ko) 2008-05-13
BRPI0615769A2 (pt) 2011-05-24
US20070054964A1 (en) 2007-03-08
CA2620164A1 (en) 2007-03-15
IL189598A0 (en) 2008-08-07
RU2008106932A (ru) 2009-10-20

Similar Documents

Publication Publication Date Title
GT200600397A (es) Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales
CL2008003096A1 (es) Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras.
DOP2009000254A (es) Derivados de piridina
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
CR11789A (es) Formulaciones orales de analogos citidina y metodos para el uso de los mismos
AR047928A1 (es) Derivados de tetrahidropiridoindol
ECSP077185A (es) Derivados de piridina
PA8622001A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
PA8586001A1 (es) Derivados de indol útiles para el tratamiento de enfermedades
PA8604301A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
DOP2006000243A (es) Derivados de pirazina
PA8719601A1 (es) Derivados de amina
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
UY28510A1 (es) Compuestos quimicos
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY31141A1 (es) Compuestos de piperidina y sus usos
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades